Susan Majka
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 24 | 2024 | 4061 | 2.440 |
Why?
| | Wnt Signaling Pathway | 6 | 2023 | 192 | 1.880 |
Why?
| | Neovascularization, Pathologic | 3 | 2025 | 301 | 1.530 |
Why?
| | Pulmonary Fibrosis | 5 | 2025 | 399 | 1.450 |
Why?
| | Stem Cells | 14 | 2023 | 592 | 1.340 |
Why?
| | Hypertension, Pulmonary | 17 | 2022 | 1904 | 1.240 |
Why?
| | Adipocytes | 8 | 2025 | 222 | 1.210 |
Why?
| | Neovascularization, Physiologic | 4 | 2020 | 178 | 1.200 |
Why?
| | Cell Separation | 6 | 2020 | 317 | 1.140 |
Why?
| | Microvessels | 3 | 2025 | 85 | 1.070 |
Why?
| | Cell Lineage | 10 | 2020 | 347 | 1.000 |
Why?
| | Cell Differentiation | 19 | 2021 | 1982 | 0.950 |
Why?
| | Endothelial Progenitor Cells | 2 | 2025 | 20 | 0.920 |
Why?
| | Capillaries | 1 | 2025 | 108 | 0.900 |
Why?
| | Adipose Tissue | 9 | 2022 | 630 | 0.890 |
Why?
| | Stem Cell Niche | 3 | 2020 | 54 | 0.820 |
Why?
| | Mice | 42 | 2025 | 17758 | 0.810 |
Why?
| | Lung Injury | 4 | 2019 | 218 | 0.790 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 405 | 0.770 |
Why?
| | beta Catenin | 3 | 2020 | 253 | 0.750 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 1036 | 0.740 |
Why?
| | Endothelium, Vascular | 5 | 2020 | 926 | 0.720 |
Why?
| | Fibrosis | 4 | 2019 | 552 | 0.700 |
Why?
| | Animals | 56 | 2025 | 36836 | 0.700 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 412 | 0.680 |
Why?
| | Airway Remodeling | 1 | 2020 | 64 | 0.650 |
Why?
| | Myeloid Cells | 4 | 2019 | 148 | 0.650 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.620 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 382 | 0.600 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 76 | 0.590 |
Why?
| | Immunophenotyping | 1 | 2020 | 319 | 0.590 |
Why?
| | Bone Marrow Cells | 7 | 2021 | 316 | 0.590 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 4 | 2017 | 51 | 0.580 |
Why?
| | Cells, Cultured | 15 | 2020 | 4192 | 0.580 |
Why?
| | Pericytes | 2 | 2017 | 33 | 0.580 |
Why?
| | PPAR gamma | 5 | 2022 | 182 | 0.560 |
Why?
| | Leukocyte Common Antigens | 5 | 2011 | 87 | 0.530 |
Why?
| | Pulmonary Artery | 11 | 2022 | 1085 | 0.500 |
Why?
| | Flow Cytometry | 7 | 2018 | 1180 | 0.500 |
Why?
| | Endothelial Cells | 5 | 2022 | 778 | 0.490 |
Why?
| | Myocytes, Smooth Muscle | 7 | 2020 | 261 | 0.480 |
Why?
| | Cell- and Tissue-Based Therapy | 3 | 2016 | 80 | 0.470 |
Why?
| | Adipocytes, White | 2 | 2015 | 19 | 0.460 |
Why?
| | Mice, Inbred C57BL | 19 | 2025 | 5750 | 0.450 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2014 | 137 | 0.440 |
Why?
| | Mesoderm | 4 | 2010 | 144 | 0.440 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 79 | 0.410 |
Why?
| | Leptin | 3 | 2025 | 236 | 0.400 |
Why?
| | Cell Proliferation | 8 | 2018 | 2476 | 0.380 |
Why?
| | Lung Diseases | 4 | 2016 | 768 | 0.370 |
Why?
| | Bleomycin | 3 | 2019 | 247 | 0.370 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 434 | 0.360 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2011 | 247 | 0.360 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 32 | 0.350 |
Why?
| | Benzimidazoles | 2 | 2011 | 168 | 0.350 |
Why?
| | Pulmonary Circulation | 3 | 2009 | 429 | 0.350 |
Why?
| | Hematopoietic Stem Cells | 7 | 2025 | 402 | 0.340 |
Why?
| | Mice, Transgenic | 12 | 2022 | 2163 | 0.340 |
Why?
| | Intra-Abdominal Fat | 1 | 2011 | 91 | 0.340 |
Why?
| | Osteoblasts | 1 | 2011 | 126 | 0.330 |
Why?
| | Pulmonary Emphysema | 3 | 2022 | 288 | 0.330 |
Why?
| | Fibroblast Growth Factor 10 | 3 | 2019 | 23 | 0.320 |
Why?
| | Familial Primary Pulmonary Hypertension | 5 | 2014 | 198 | 0.320 |
Why?
| | Osteogenesis | 1 | 2011 | 186 | 0.310 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4281 | 0.310 |
Why?
| | Hypoxia | 9 | 2021 | 1112 | 0.300 |
Why?
| | Respiratory System | 1 | 2009 | 157 | 0.280 |
Why?
| | Regeneration | 5 | 2019 | 195 | 0.280 |
Why?
| | Phenotype | 7 | 2020 | 3189 | 0.270 |
Why?
| | Humans | 39 | 2024 | 136750 | 0.260 |
Why?
| | Mice, Knockout | 7 | 2021 | 3009 | 0.260 |
Why?
| | Immunomodulation | 2 | 2021 | 98 | 0.250 |
Why?
| | Myofibroblasts | 2 | 2019 | 126 | 0.250 |
Why?
| | Mutation | 2 | 2021 | 3947 | 0.240 |
Why?
| | Apoptosis | 4 | 2013 | 2552 | 0.240 |
Why?
| | Vasoconstriction | 2 | 2017 | 202 | 0.240 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2002 | 56 | 0.240 |
Why?
| | Superoxide Dismutase | 3 | 2014 | 346 | 0.230 |
Why?
| | Vascular Remodeling | 3 | 2022 | 190 | 0.220 |
Why?
| | Respiratory Mucosa | 2 | 2019 | 322 | 0.220 |
Why?
| | Pneumoconiosis | 1 | 2024 | 19 | 0.220 |
Why?
| | Coal Mining | 1 | 2024 | 23 | 0.210 |
Why?
| | Cell Line | 3 | 2020 | 2838 | 0.210 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2023 | 2184 | 0.200 |
Why?
| | Muscle, Smooth, Vascular | 4 | 2015 | 445 | 0.200 |
Why?
| | Granuloma, Respiratory Tract | 1 | 2002 | 12 | 0.200 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1993 | 0.190 |
Why?
| | Cryptococcus neoformans | 1 | 2002 | 21 | 0.190 |
Why?
| | Cryptococcosis | 1 | 2002 | 27 | 0.190 |
Why?
| | Retinal Neovascularization | 1 | 2002 | 25 | 0.190 |
Why?
| | Insulin Resistance | 2 | 2025 | 1203 | 0.180 |
Why?
| | Cell Hypoxia | 2 | 2020 | 226 | 0.180 |
Why?
| | Epithelial Cells | 4 | 2020 | 1094 | 0.180 |
Why?
| | Hemopexin | 1 | 2021 | 27 | 0.180 |
Why?
| | Urokinase-Type Plasminogen Activator | 2 | 1999 | 29 | 0.180 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2021 | 14 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 94 | 0.180 |
Why?
| | Acute Lung Injury | 2 | 2017 | 287 | 0.180 |
Why?
| | Tamoxifen | 2 | 2019 | 202 | 0.170 |
Why?
| | Calgranulin B | 1 | 2020 | 10 | 0.170 |
Why?
| | Fibroblasts | 3 | 2018 | 993 | 0.170 |
Why?
| | Cigarette Smoking | 1 | 2022 | 101 | 0.170 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2020 | 11 | 0.170 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 43 | 0.170 |
Why?
| | Myocardium | 4 | 2019 | 1001 | 0.170 |
Why?
| | Occupational Exposure | 1 | 2024 | 338 | 0.170 |
Why?
| | Male | 19 | 2020 | 67305 | 0.160 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 29 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 858 | 0.160 |
Why?
| | Muscle, Skeletal | 3 | 2009 | 1707 | 0.160 |
Why?
| | Vascular System Injuries | 1 | 2020 | 71 | 0.160 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 27 | 0.160 |
Why?
| | Biomarkers | 5 | 2021 | 4145 | 0.160 |
Why?
| | Smoke | 1 | 2020 | 140 | 0.160 |
Why?
| | Cell Culture Techniques | 2 | 2020 | 362 | 0.150 |
Why?
| | Receptor, Serotonin, 5-HT2B | 1 | 2018 | 2 | 0.150 |
Why?
| | RNA Stability | 1 | 2020 | 117 | 0.150 |
Why?
| | Myeloid Progenitor Cells | 1 | 2018 | 17 | 0.150 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 127 | 0.150 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 145 | 0.150 |
Why?
| | Female | 17 | 2025 | 72785 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 114 | 0.140 |
Why?
| | Cicatrix | 1 | 2018 | 64 | 0.140 |
Why?
| | Benzaldehydes | 1 | 2017 | 8 | 0.140 |
Why?
| | Laryngostenosis | 1 | 2018 | 51 | 0.140 |
Why?
| | Interleukin-17 | 1 | 2018 | 119 | 0.140 |
Why?
| | Cadherins | 1 | 2019 | 205 | 0.140 |
Why?
| | Membrane Proteins | 2 | 2022 | 1163 | 0.140 |
Why?
| | Anemia, Sickle Cell | 1 | 2021 | 269 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2020 | 513 | 0.140 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 262 | 0.140 |
Why?
| | Niacinamide | 1 | 2017 | 79 | 0.140 |
Why?
| | Integrin beta1 | 1 | 2017 | 25 | 0.140 |
Why?
| | Thiazolidinediones | 2 | 2009 | 137 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2021 | 595 | 0.130 |
Why?
| | Heart | 2 | 1999 | 653 | 0.130 |
Why?
| | Protein Stability | 1 | 2017 | 176 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2002 | 1242 | 0.130 |
Why?
| | Signal Transduction | 8 | 2019 | 5077 | 0.130 |
Why?
| | MicroRNAs | 1 | 2022 | 692 | 0.120 |
Why?
| | Hemoglobins | 2 | 2021 | 353 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 72 | 0.120 |
Why?
| | Trans-Activators | 1 | 1997 | 398 | 0.120 |
Why?
| | Gene Expression Regulation | 5 | 2022 | 2605 | 0.110 |
Why?
| | Promoter Regions, Genetic | 3 | 2015 | 1249 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 278 | 0.110 |
Why?
| | Repressor Proteins | 1 | 1997 | 427 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 1 | 1997 | 647 | 0.110 |
Why?
| | Inflammation | 3 | 2022 | 2835 | 0.110 |
Why?
| | Cell Fusion | 2 | 2015 | 51 | 0.110 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2014 | 165 | 0.110 |
Why?
| | Animals, Newborn | 2 | 2009 | 844 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 2 | 2022 | 558 | 0.100 |
Why?
| | Vascular Stiffness | 1 | 2018 | 492 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2412 | 0.100 |
Why?
| | Aging | 1 | 2023 | 1863 | 0.100 |
Why?
| | Macrophages | 3 | 2022 | 1544 | 0.100 |
Why?
| | Adult | 5 | 2020 | 37626 | 0.100 |
Why?
| | Hydrogen Peroxide | 2 | 2012 | 327 | 0.100 |
Why?
| | Insulin | 2 | 2022 | 2406 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2018 | 1059 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 70 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| | Models, Biological | 4 | 2021 | 1773 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 975 | 0.100 |
Why?
| | ADAM Proteins | 2 | 2022 | 61 | 0.100 |
Why?
| | Early Growth Response Protein 1 | 2 | 2010 | 27 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1044 | 0.090 |
Why?
| | Cytological Techniques | 1 | 2011 | 27 | 0.090 |
Why?
| | Receptor, TIE-2 | 1 | 2011 | 12 | 0.090 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 216 | 0.090 |
Why?
| | Mice, Nude | 2 | 2011 | 696 | 0.090 |
Why?
| | Ventricular Pressure | 1 | 2011 | 48 | 0.090 |
Why?
| | Regenerative Medicine | 1 | 2011 | 47 | 0.090 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.090 |
Why?
| | Osteocalcin | 1 | 2011 | 37 | 0.090 |
Why?
| | Mice, Inbred ICR | 1 | 2011 | 119 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 766 | 0.090 |
Why?
| | Diet, High-Fat | 1 | 2012 | 247 | 0.090 |
Why?
| | Adipocytes, Brown | 1 | 2010 | 7 | 0.090 |
Why?
| | World Health Organization | 1 | 2011 | 123 | 0.090 |
Why?
| | Cytogenetic Analysis | 1 | 2010 | 33 | 0.090 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2011 | 135 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 366 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 1997 | 1501 | 0.080 |
Why?
| | Lymphoid Progenitor Cells | 1 | 2009 | 11 | 0.080 |
Why?
| | Extracellular Space | 1 | 2010 | 119 | 0.080 |
Why?
| | Vascular Diseases | 1 | 2012 | 243 | 0.080 |
Why?
| | Bronchoconstriction | 1 | 2009 | 32 | 0.080 |
Why?
| | Syndecan-4 | 1 | 2009 | 7 | 0.080 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1772 | 0.080 |
Why?
| | Ventricular Function, Right | 1 | 2011 | 282 | 0.080 |
Why?
| | AC133 Antigen | 1 | 2008 | 19 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2009 | 2831 | 0.080 |
Why?
| | Giant Cells | 1 | 2008 | 24 | 0.080 |
Why?
| | Neprilysin | 1 | 2009 | 47 | 0.080 |
Why?
| | Genotype | 2 | 2011 | 1914 | 0.080 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2009 | 29 | 0.080 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 208 | 0.070 |
Why?
| | Hyperoxia | 1 | 2009 | 90 | 0.070 |
Why?
| | Muscle, Smooth | 1 | 2009 | 155 | 0.070 |
Why?
| | Case-Control Studies | 4 | 2021 | 3540 | 0.070 |
Why?
| | Infant, Newborn, Diseases | 1 | 2009 | 113 | 0.070 |
Why?
| | Thrombosis | 1 | 2011 | 366 | 0.070 |
Why?
| | Receptor for Advanced Glycation End Products | 2 | 2020 | 33 | 0.070 |
Why?
| | Vasodilator Agents | 1 | 2009 | 331 | 0.070 |
Why?
| | Activating Transcription Factor 1 | 1 | 2006 | 9 | 0.070 |
Why?
| | Middle Aged | 5 | 2020 | 33225 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 15 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 32 | 0.060 |
Why?
| | Glycoproteins | 1 | 2008 | 342 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1733 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 543 | 0.060 |
Why?
| | RNA, Small Interfering | 4 | 2011 | 622 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2009 | 621 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 617 | 0.060 |
Why?
| | Bone Marrow Transplantation | 3 | 2019 | 287 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 521 | 0.060 |
Why?
| | Cytokines | 3 | 2021 | 2084 | 0.060 |
Why?
| | Pyrroles | 2 | 2018 | 213 | 0.060 |
Why?
| | Ovariectomy | 1 | 2025 | 152 | 0.060 |
Why?
| | Age Factors | 2 | 2010 | 3286 | 0.060 |
Why?
| | Adiponectin | 2 | 2022 | 244 | 0.060 |
Why?
| | Sex Factors | 1 | 2010 | 2064 | 0.060 |
Why?
| | Silicates | 1 | 2024 | 15 | 0.060 |
Why?
| | Coal | 1 | 2024 | 19 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2024 | 200 | 0.050 |
Why?
| | Young Adult | 1 | 2020 | 13126 | 0.050 |
Why?
| | Dust | 1 | 2024 | 100 | 0.050 |
Why?
| | Blotting, Western | 3 | 2012 | 1225 | 0.050 |
Why?
| | Aged | 3 | 2020 | 23800 | 0.050 |
Why?
| | Muscle Cells | 1 | 2003 | 43 | 0.050 |
Why?
| | Sepsis | 1 | 2009 | 614 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2014 | 145 | 0.050 |
Why?
| | Guanine | 1 | 2003 | 79 | 0.050 |
Why?
| | Wound Healing | 2 | 2003 | 328 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2024 | 114 | 0.050 |
Why?
| | Indoles | 2 | 2018 | 410 | 0.050 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 256 | 0.050 |
Why?
| | Peptides | 1 | 2008 | 981 | 0.050 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2002 | 15 | 0.050 |
Why?
| | Endothelium | 1 | 2003 | 122 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 851 | 0.050 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 94 | 0.050 |
Why?
| | Stem Cell Transplantation | 4 | 2006 | 176 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 66 | 0.050 |
Why?
| | ADAM17 Protein | 1 | 2002 | 35 | 0.050 |
Why?
| | Ceramides | 1 | 2022 | 118 | 0.050 |
Why?
| | Multipotent Stem Cells | 1 | 2002 | 20 | 0.050 |
Why?
| | Metalloendopeptidases | 1 | 2002 | 62 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 1 | 2002 | 124 | 0.050 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2014 | 204 | 0.050 |
Why?
| | Quail | 2 | 1999 | 6 | 0.050 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 219 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2002 | 329 | 0.050 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2002 | 132 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2002 | 164 | 0.040 |
Why?
| | Heme | 1 | 2021 | 78 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 311 | 0.040 |
Why?
| | Phosphoproteins | 2 | 2017 | 337 | 0.040 |
Why?
| | Cell Division | 3 | 2009 | 796 | 0.040 |
Why?
| | Models, Animal | 1 | 2002 | 384 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2001 | 190 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 206 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 839 | 0.040 |
Why?
| | Vital Capacity | 1 | 2020 | 309 | 0.040 |
Why?
| | Rats | 3 | 2013 | 5639 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 345 | 0.040 |
Why?
| | Epithelium | 1 | 2020 | 311 | 0.040 |
Why?
| | Hepatocyte Growth Factor | 1 | 1999 | 35 | 0.040 |
Why?
| | Benzodioxoles | 1 | 2020 | 115 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 393 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2982 | 0.040 |
Why?
| | Arterioles | 1 | 2018 | 52 | 0.040 |
Why?
| | Quinazolines | 1 | 2020 | 250 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 810 | 0.040 |
Why?
| | Monocytes | 1 | 2021 | 563 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2018 | 189 | 0.040 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 4 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2019 | 466 | 0.040 |
Why?
| | Transfection | 2 | 2013 | 941 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2009 | 6031 | 0.030 |
Why?
| | DNA Primers | 2 | 2009 | 514 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1997 | 56 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 91 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2017 | 184 | 0.030 |
Why?
| | Embryo, Nonmammalian | 1 | 1997 | 167 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 1 | 2018 | 226 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 816 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2013 | 2486 | 0.030 |
Why?
| | Adipogenesis | 1 | 2017 | 55 | 0.030 |
Why?
| | Bioengineering | 1 | 2016 | 18 | 0.030 |
Why?
| | Fibrin | 1 | 2017 | 81 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 642 | 0.030 |
Why?
| | Blood Pressure | 2 | 2014 | 1774 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2751 | 0.030 |
Why?
| | Hemodynamics | 2 | 2012 | 1109 | 0.030 |
Why?
| | RNA | 1 | 2002 | 921 | 0.030 |
Why?
| | GTP Cyclohydrolase | 1 | 2014 | 9 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| | Muscle Development | 2 | 2009 | 111 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 22 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 969 | 0.030 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 37 | 0.030 |
Why?
| | Estrogen Antagonists | 1 | 2014 | 45 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2014 | 93 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 10747 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2017 | 429 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 785 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 886 | 0.030 |
Why?
| | Genome, Human | 1 | 2016 | 423 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1936 | 0.030 |
Why?
| | Monocrotaline | 1 | 2013 | 28 | 0.030 |
Why?
| | S100 Proteins | 1 | 2013 | 37 | 0.030 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 219 | 0.020 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 29 | 0.020 |
Why?
| | Infusion Pumps | 1 | 2012 | 32 | 0.020 |
Why?
| | Spin Labels | 1 | 2012 | 48 | 0.020 |
Why?
| | Chronic Disease | 2 | 2009 | 1786 | 0.020 |
Why?
| | Smoking | 1 | 2020 | 1620 | 0.020 |
Why?
| | Glycation End Products, Advanced | 1 | 2013 | 82 | 0.020 |
Why?
| | Societies, Medical | 1 | 2016 | 816 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2013 | 125 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2012 | 153 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2012 | 139 | 0.020 |
Why?
| | Cardiac Output | 1 | 2012 | 164 | 0.020 |
Why?
| | Rats, Inbred WKY | 1 | 2011 | 36 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1009 | 0.020 |
Why?
| | Free Radical Scavengers | 1 | 2011 | 88 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 614 | 0.020 |
Why?
| | Time Factors | 1 | 2002 | 6808 | 0.020 |
Why?
| | Naphthalenes | 1 | 2011 | 60 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2013 | 206 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 466 | 0.020 |
Why?
| | Gene Expression | 2 | 2008 | 1500 | 0.020 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 91 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 844 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2011 | 209 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2016 | 1428 | 0.020 |
Why?
| | Tyrosine | 1 | 2010 | 222 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10330 | 0.020 |
Why?
| | Syndecan-3 | 1 | 2009 | 7 | 0.020 |
Why?
| | Transcription Factors | 1 | 1997 | 1718 | 0.020 |
Why?
| | PAX7 Transcription Factor | 1 | 2009 | 13 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2011 | 437 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 123 | 0.020 |
Why?
| | Capillary Permeability | 1 | 2009 | 145 | 0.020 |
Why?
| | Child | 1 | 2008 | 21816 | 0.020 |
Why?
| | Neoplasms | 1 | 2003 | 2643 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 480 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2006 | 17 | 0.020 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2006 | 18 | 0.020 |
Why?
| | Collagenases | 1 | 2006 | 25 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2012 | 915 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 378 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2006 | 36 | 0.020 |
Why?
| | CD11 Antigens | 1 | 2006 | 30 | 0.020 |
Why?
| | Cell Movement | 1 | 2011 | 968 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2010 | 441 | 0.020 |
Why?
| | Blood Vessels | 1 | 2008 | 187 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1059 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2007 | 131 | 0.020 |
Why?
| | Heart Failure | 1 | 2019 | 2230 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2012 | 1314 | 0.010 |
Why?
| | Muscle Proteins | 1 | 2007 | 228 | 0.010 |
Why?
| | Antioxidants | 1 | 2009 | 584 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2006 | 390 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1350 | 0.010 |
Why?
| | Dietary Fats | 1 | 2006 | 304 | 0.010 |
Why?
| | Base Sequence | 1 | 2008 | 2179 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1467 | 0.010 |
Why?
| | O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 6 | 0.010 |
Why?
| | Carmustine | 1 | 2003 | 50 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2003 | 115 | 0.010 |
Why?
| | Half-Life | 1 | 2003 | 164 | 0.010 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2003 | 73 | 0.010 |
Why?
| | Cell Survival | 1 | 2006 | 1116 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2003 | 67 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 2003 | 412 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2006 | 769 | 0.010 |
Why?
| | Molecular Probes | 1 | 2002 | 36 | 0.010 |
Why?
| | Radiation Chimera | 1 | 2001 | 30 | 0.010 |
Why?
| | Cell Transplantation | 1 | 2001 | 37 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 304 | 0.010 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2001 | 134 | 0.010 |
Why?
| | Myocardial Ischemia | 1 | 2001 | 262 | 0.010 |
Why?
| | United States | 1 | 2016 | 14682 | 0.010 |
Why?
| | Chick Embryo | 1 | 1999 | 130 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 534 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2006 | 1283 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 792 | 0.010 |
Why?
|
|
Majka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|